Skip to main content

Osteopenia and fractures in cystinotic children post renal transplantation

Pediatric Nephrology volume 18, pages 384–390 (2003)Cite this article

Abstract.

Many of the end-organ effects of cystinosis are known to be risk factors for osteopenia; these include deposition of cystine crystals in bone, hypothyroidism, diabetes mellitus, primary hypogonadism, urinary phosphate wasting, and chronic renal failure. While transplantation may correct the latter, it exposes the child to other risk factors for diminished bone mass, notably the use of high-dose glucocorticoids. Our objective was to determine if these multiple risk factors translate into an increased occurrence of osteopenia, as measured by dual-energy X-ray absorptiometry (DEXA), and/or fractures in this population. We examined the charts, X-rays, and bone mineral density (BMD) of all cystinotic patients post renal transplant for whom this information was available. Lumbar spine BMD was measured by DEXA scan (Hologic 4500). Z-scores were corrected for growth parameters using previously published reference data. Fracture history and pertinent serum markers of bone metabolism were also analyzed. Of the 63 renal transplants performed at our institution, 11 children were transplanted due to cystinosis. Nine of these patients, 5 male and 4 female, had had BMD evaluations, with an average age of 14.3 years (range 5–17 years) at the time of initial BMD post transplant. The mean interval between transplant and BMD evaluation was 39 months (range 3–90 months). Surprisingly, 7 of 9 patients had normal uncorrected BMD values (z-scores −1.92 to +0.02) and 7 of 9 patients had normal corrected values (z-scores –1.20 to +1.93). Three patients suffered from a total of eight fractures. Of the 3 fracture patients, 2 had normal BMD. All patients maintained good graft function and had normal calcium/phosphate mineral status. Of note, 3 of 5 male patients had evidence of primary testicular failure at earlier ages than often described, and this may be an unrecognized risk factor for bone disease in this population. Despite the numerous risk factors for developing osteopenia, these results suggest that the majority of cystinotic patients post renal transplant do not experience reduced bone mineral content as measured by DEXA. However, the significant fracture history among these patients demonstrates that DEXA cannot be used to assess fracture risk in patients with nephropathic cystinosis.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1.

References

  1. Gahl WA, Renlund M, Thoene JG (1989) Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In: Scriver CR (ed) The metabolic basis of inherited disease. McGraw Hill, New York

  2. Gahl WA (1986) Cystinosis coming of age. Adv Pediatr 33:95–126

    CAS  PubMed  Google Scholar 

  3. Gahl WA, Kaiser-Kupfer MI (1987) Complications of nephropathic cystinosis after renal failure. Pediatr Nephrol 1:260–268

    CAS  PubMed  Google Scholar 

  4. Haffner D, Scharer K (1999) Long term outcome of pediatric patients with hereditary tubular disorders. Nephron 83:250–260

    CAS  PubMed  Google Scholar 

  5. Fivush B, Green OC, Porter CC, Balfe JW, O'Regan S, Gahl WA (1987) Pancreatic endocrine insufficiency in posttransplant cystinosis. Am J Dis Child 141:1087–1089

    CAS  PubMed  Google Scholar 

  6. Chik CL, Friedman A, Merriam GR, Gahl WA (1993) Pituitary-testicular function in nephropathic cystinosis. Ann Intern Med 119:568–575

    CAS  PubMed  Google Scholar 

  7. Dempster DW, Arlot MA, Meunier PJ (1983) Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 35:410–417

    CAS  PubMed  Google Scholar 

  8. Reid IR, Heap SW (1990) Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 150:2545–2548

    CAS  PubMed  Google Scholar 

  9. Slatopolsky E, Martin K (1984) Glucocorticoids and renal transplant osteonecrosis. Adv Exp Med Biol 171:353–359

    CAS  PubMed  Google Scholar 

  10. Chesney RW, Rose PG, Mazess RB (1984) Persistence of diminished bone mineral content following renal transplantation in childhood. Pediatrics 73:459–466

    CAS  PubMed  Google Scholar 

  11. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544–550

    CAS  PubMed  Google Scholar 

  12. Feber J, Cochat P, Braillon P, Castelo F, Martin X, Glastre C, Chapuis F, David L, Meunier P (1994) Bone mineral density after renal transplantation. J Pediatr 125:870–875

    CAS  PubMed  Google Scholar 

  13. Boot A, Nauta J, Hokken-Koelega A, Pols H, deRidder M, Muinck Keizer-Schrama S (1995) Renal transplantation and osteoporosis. Arch Dis Child 72:502–506

    CAS  PubMed  Google Scholar 

  14. Johnston GC, Slemenda CW, Melton LJ (1991) Clinical use of bone densitometry. N Engl J Med 324:1105–1109

    PubMed  Google Scholar 

  15. Glastre C, Braillon P, David L, Cochat P, Meunier PJ, Delmas PD (1990) Measurement of bone mineral content of the lumbar spine by dual energy X-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab 70:1330–1333

    CAS  PubMed  Google Scholar 

  16. Klaus G, Paschen C, Wuster C, Kovacs GT, Barden J, Mehls O, Scharer K (1998) Weight-/height-related bone mineral density is not reduced after renal transplantation. Pediatr Nephrol 12:343–348

    Article  CAS  PubMed  Google Scholar 

  17. Reusz G, Szabo A, Peter F, Kenesei E, Sallay P, Latta K, Szabo A, Szabo A, Tulassay T (2000) Bone metabolism and mineral density following renal transplantation. Arch Dis Child 83:146–151

    Article  CAS  PubMed  Google Scholar 

  18. Sanchez CP, Salusky IB, Kuizon BD, Ramirez JA, Gales B, Ettenger RB, Goodman WG (1998) Bone disease in children and adolescents undergoing successful renal transplantation. Kidney Int 53:1358–1364

    CAS  PubMed  Google Scholar 

  19. Offner G, Latta K, Hoyer PF, Baum H-J, Ehrich JHH, Pichlmayr R, Brodehl J (1999) Kidney transplanted children come of age. Kidney Int 55:1509–1517

    CAS  PubMed  Google Scholar 

  20. Warner JT, Cowan FJ, Dunstan FDJ, Evans WD, Webb DKH, Gregory JW (1998) Measured and predicted bone mineral content in healthy boys and girls aged 6–18 years: adjustment for body size and puberty. Acta Paediatr 87:244–249

    Article  CAS  PubMed  Google Scholar 

  21. Molgaard C, Thomsen BL, Prentice A, Cole TJ, Michaelsen KF (1997) Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 76:9–15

    CAS  Google Scholar 

  22. Cueto-Manzano AM, Konel S, Hutchison AJ (1999) Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney Int 55:2021–2029

    Article  CAS  PubMed  Google Scholar 

  23. DelPozo E, Lippuner K, Ruch W, Casez JP, Payne T, Mackenzie A, Jaeger P (1995) Different effects of cyclosporin-A on bone remodeling in young and adult rats. Dial Transplant Nephrol 16:271S-275S

    CAS  Google Scholar 

  24. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S (1988) Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123:2571–2577

    CAS  PubMed  Google Scholar 

  25. Bourbigot B, Moal MC, Cledes J (1999) Bone histology in renal transplant patients receiving cyclosporin. Lancet I:1048–1049

    Google Scholar 

  26. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J (2001) Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 68:83–86

    CAS  PubMed  Google Scholar 

  27. Stempfle HU, Werner C, Siebert U, Assum T, Wehr U, Rambeck WA, Meiser B, Theisen K, Gartner R (2002) The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal randomized, double-blind trial with calcitriol. Transplantation 73:547–552

    CAS  PubMed  Google Scholar 

  28. Inoue T, Kawamura I, Matsuo M, Aketa M, Mabuchi M, Seki J, Goto T (2000) Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. Transplantation 70:774–779

    CAS  PubMed  Google Scholar 

  29. Schönau E (1998) Problems of bone analysis in childhood and adolescence. Pediatr Nephrol 12:420–429

    PubMed  Google Scholar 

  30. Brenner B, Rector F (2000) The kidney, vol 2, 6th edn. Saunders, Philadelphia, pp 1807–1808

  31. Sellers E, Sharma A, Rodd C (1998) The use of pamidronate in three children with renal disease. Pediatr Nephrol 12:778–781

    Article  CAS  PubMed  Google Scholar 

  32. Grimston SK, Morrison K, Harder JA, Hanley OA (1992) Bone mineral density during puberty in western Canadian children. Bone Miner 19:85–86

    CAS  PubMed  Google Scholar 

  33. Kroger H, Kotaniemi A, Kroger L, Alhava E (1993) Development of bone mass and bone density of the spine and femoral neck-a prospective study of 65 children and adolescents. Bone Miner 23:171–182

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Pediatric Endocrinology, Montreal Children's Hospital, McGill University Health Center, Montreal, Quebec, Canada

    Paul James A. Zimakas & Celia J. Rodd

  2. Department of Pediatric Nephrology, Montreal Children's Hospital, McGill University Health Center, Montreal, Quebec, Canada

    Atul K. Sharma

  3. Montreal Children's Hospital, 2300 Tupper Street, Montreal, Quebec, H3H 1P3, Canada

    Paul James A. Zimakas

Authors
  1. Paul James A. Zimakas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atul K. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Celia J. Rodd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul James A. Zimakas.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zimakas, P.J.A., Sharma, A.K. & Rodd, C.J. Osteopenia and fractures in cystinotic children post renal transplantation. Pediatr Nephrol 18, 384–390 (2003). https://doi.org/10.1007/s00467-003-1093-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1093-5

Keywords

  • Bone mineral density
  • Dual-energy X-ray absorptiometry
  • Cystinosis
  • Short stature
  • Glucocorticoids
  • Testicular failure